Source:http://linkedlifedata.com/resource/pubmed/id/21652214
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
13
|
pubmed:dateCreated |
2011-6-24
|
pubmed:abstractText |
Linarin, a natural occurring flavanol glycoside derived from Mentha arvensis and Buddleja davidii is known to have anti-acetylcholinesterase effects. The present study intended to explore the neuroprotective effects of linarin against A?(25-35)-induced neurotoxicity with cultured rat pheochromocytoma cells (PC12 cells) and the possible mechanisms involved. For this purpose, PC12 cells were cultured and exposed to 30 ?M A?(25-35) in the absence or presence of linarin (0.1, 1.0 and 10 ?M). In addition, the potential contribution of the PI3K/Akt neuroprotective pathway in linarin-mediated protection against A?(25-35)-induced neurotoxicity was also investigated. The results showed that linarin dose-dependently increased cell viability and reduced the number of apoptotic cells as measured by MTT assay, Annexin-V/PI staining, JC-1 staining and caspase-3 activity assay. Linarin could also inhibit acetylcholinesterase activity induced by A?(25-35) in PC12 cells. Further study revealed that linarin induced the phosphorylation of Akt dose-dependently. Treatment of PC12 cells with the PI3K inhibitor LY294002 attenuated the protective effects of linarin. Furthermore, linarin also stimulated phosphorylation of glycogen synthase kinase-3? (GSK-3?), a downstream target of PI3K/Akt. Moreover, the expression of the anti-apoptotic protein Bcl-2 was also increased by linarin treatment. These results suggest that linarin prevents A?(25-35)-induced neurotoxicity through the activation of PI3K/Akt, which subsequently inhibits GSK-3? and up-regulates Bcl-2. These findings raise the possibility that linarin may be a potent therapeutic compound against Alzheimer's disease acting through both acetylcholinesterase inhibition and neuroprotection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amyloid beta-Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Glycosides,
http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt,
http://linkedlifedata.com/resource/pubmed/chemical/amyloid beta-protein (25-35),
http://linkedlifedata.com/resource/pubmed/chemical/linarin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1464-3391
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4021-7
|
pubmed:meshHeading |
pubmed-meshheading:21652214-Amyloid beta-Peptides,
pubmed-meshheading:21652214-Animals,
pubmed-meshheading:21652214-Apoptosis,
pubmed-meshheading:21652214-Caspase 3,
pubmed-meshheading:21652214-Cell Line, Tumor,
pubmed-meshheading:21652214-Glycosides,
pubmed-meshheading:21652214-Neurons,
pubmed-meshheading:21652214-Neuroprotective Agents,
pubmed-meshheading:21652214-Peptide Fragments,
pubmed-meshheading:21652214-Phosphatidylinositol 3-Kinases,
pubmed-meshheading:21652214-Proto-Oncogene Proteins c-akt,
pubmed-meshheading:21652214-Rats
|
pubmed:year |
2011
|
pubmed:articleTitle |
Neuroprotective effects of linarin through activation of the PI3K/Akt pathway in amyloid-?-induced neuronal cell death.
|
pubmed:affiliation |
Department of Pharmacology, School of Medicine, Shandong University, Shandong, PR China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|